The company
Arbutus Biopharma Corporation
ABUS · Nasdaq
ABUS stood above a rising 150-day average in 26 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 7.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 3
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 170 (+12)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 26 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Two Seas Capital LPadded · filed 12 Aug 2026 | 19,095,583$91.7M | +538,040+2.9% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 17,698,305$85.0M | -8,193,175−31.6% |
| Whitefort Capital Management, LPadded · filed 14 Aug 2026 | 15,794,261$75.8M | +863,376+5.8% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 13,766,071$66.1M | +799,125+6.2% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 7,869,179$37.8M | +1,526,669+24.1% |
| Rubric Capital Management LPadded · filed 14 Aug 2026 | 7,532,937$36.2M | +906,548+13.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 7,010,679$33.7M | +321,768+4.8% |
| BARCLAYS PLCreduced · filed 14 Aug 2026 | 4,207,914$20.2M | -108,181−2.5% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 4,117,691$19.8M | +345,885+9.2% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 3,506,802$16.8M | +2,406,368+218.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.